Literature DB >> 8439636

Gastric and duodenal mucosal blood flow in patients receiving non-steroidal anti-inflammatory drugs--influence of age, smoking, ulceration and Helicobacter pylori.

A S Taha1, W Angerson, I Nakshabendi, H Beekman, C Morran, R D Sturrock, R I Russell.   

Abstract

Using laser Doppler flowmetry, we measured gastric and duodenal mucosal blood flow in 70 patients who had taken non-steroidal anti-inflammatory drugs (NSAIDs) for longer than 4 weeks, and studied the correlation with demographic factors, ulceration, and Helicobacter pylori. Blood flow was also measured in 17 other subjects not taking any drugs. Measurements were taken from healthy-looking mucosa in the gastric antrum and the first part of the duodenum. Both gastric and duodenal blood flow values were significantly lower in patients taking NSAID than in those who did not. In the NSAID group, the median duodenal mucosal blood flow was 150 perfusion units in smokers (n = 29) compared with 175 in non-smokers (P = 0.024), 123 units in patients with duodenal ulcers (n = 12) compared with 160 in those without duodenal ulcers (P = 0.020), 135 units in patients with H. pylori (n = 30) compared with 168 in patients without H. pylori (P = 0.033), and 118 in smokers infected with H. pylori compared with 175 units in non-smokers not infected with H. pylori (F = 13.4, P = 0.0005). There was no correlation with age. Gastric blood flow was not significantly influenced by any of the above variables. These results suggest that chronic NSAID intake is associated with reduced blood flow in both the stomach and duodenum. However, amongst NSAID patients, duodenal, but not gastric, mucosal blood flow is reduced in smokers, and in those with duodenal ulcers and H. pylori.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8439636     DOI: 10.1111/j.1365-2036.1993.tb00067.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  10 in total

1.  Focal reduction of villous blood flow in early indomethacin enteropathy: a dynamic vascular study in the rat.

Authors:  D A Kelly; C Piasecki; A Anthony; A P Dhillon; R E Pounder; A J Wakefield
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

2.  Helicobacter pylori and non-steroidal anti-inflammatory drugs: uncomfortable partners in peptic ulcer disease.

Authors:  A S Taha; R I Russell
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

3.  Influence of Helicobacter pylori on gastric mucosal adaptation to naproxen in man.

Authors:  G R Lipscomb; N Wallis; G Armstrong; M J Goodman; W D Rees
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

4.  Potentiating effect of passive cigarette smoking on gastrointestinal damage induced by indomethacin in rats.

Authors:  X Guo; Q B Mei; C H Cho
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

Review 5.  Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives.

Authors:  F Halter; A S Tarnawski; A Schmassmann; B M Peskar
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

6.  Severe gastric mucosal damage induced by NSAIDs in healthy subjects is associated with Helicobacter pylori infection and high levels of serum pepsinogens.

Authors:  L Santucci; S Fiorucci; L Patoia; F M Di Matteo; P M Brunori; A Morelli
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

7.  Mucosal erosions in longterm non-steroidal anti-inflammatory drug users: predisposition to ulceration and relation to Helicobacter pylori.

Authors:  A S Taha; R D Sturrock; R I Russell
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

8.  Predicting NSAID related ulcers--assessment of clinical and pathological risk factors and importance of differences in NSAID.

Authors:  A S Taha; S Dahill; R D Sturrock; F D Lee; R I Russell
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

Review 9.  Helicobacter pylori and smoking: two additive risk factors for organic dyspepsia.

Authors:  F Halter; R Brignoli
Journal:  Yale J Biol Med       Date:  1998 Mar-Apr

Review 10.  Improving the gastrointestinal tolerability of aspirin in older people.

Authors:  Julia L Newton
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.